Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer

MLA

Xavier Guardia, et al. Immune Microenvironment Characterisation and Dynamics during Anti-HER2-Based Neoadjuvant Treatment in HER2-Positive Breast Cancer. Mar. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1fdf40b010ab233d3dd68511f1fed0a&authtype=sso&custid=ns315887.

APA

Xavier Guardia, Garazi Serna, J. Cortés, Begoña Bermejo, Roberta Fasani, Patricia Galván, Gaia Griguolo, Nuria Chic, Luis Manso, Serafin Morales, N. Martínez, I Garau, Maria Vidal, Montse Muñoz, Antonio Llombart-Cussac, Mafalda Oliveira, Paolo Nuciforo, Aleix Prat, Laia Paré, … Ramon Lopez. (2021). Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer.

Chicago

Xavier Guardia, Garazi Serna, J. Cortés, Begoña Bermejo, Roberta Fasani, Patricia Galván, Gaia Griguolo, et al. 2021. “Immune Microenvironment Characterisation and Dynamics during Anti-HER2-Based Neoadjuvant Treatment in HER2-Positive Breast Cancer,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d1fdf40b010ab233d3dd68511f1fed0a&authtype=sso&custid=ns315887.